Publication | Closed Access
Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination
17
Citations
0
References
2021
Year
The patients with mCRPC harboring alterations in different HR genes displayed distinct response to platinum-based chemotherapy. Patients with mCRPC harboring genomic defects in crucial HR genes either in the germline or somatic, especially <i>BRCA2</i> and <i>ATM</i>, might experience superior outcomes to platinum-based chemotherapy, compared with those harboring <i>CDK12</i> defect.